Lupin gets USFDA nod to market generic anti-bacterial drug

Posted by Someone on January 22, 2023  •  Comments (64)  • 

The company has received final approval from the US Food and Drug Administration (US FDA) to market metronidazole tablets in strengths of 250 mg and 500 mg, said Lupin.

Aurobindo Pharma has received US health regulator's approval to manufacture and market Metronidazole Tablets, used to treat various kinds of infections, in the US market.